(redirected from goserelin acetate)
Also found in: Medical.
Related to goserelin acetate: Cosudex


A synthetic peptide analog of gonadotropin-releasing hormone used to treat prostate cancer, endometriosis, and advanced breast cancer.

[Blend of gonadorelin (from gonado(tropin-)rel(easing hormone) + -in) and serine.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n goserelina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Three-month depot of goserelin acetate: clinical efficacy and endocrine profile.
This international, multi-center, randomised, open-label study will assess the safety and efficacy of a monthly dosing regimen of ozarelix administered subcutaneously (SC) versus ZOLADEX (goserelin acetate) depot.
Hormone therapy consisted of the LHRH agonist goserelin acetate (Zoladex) as a 1-month, 3.6-mg depot formulation and then a 3-month, 11.8-mg depot plus a leuprolide acetate (Lupron) depot of 7.5 mg per vial for I month and of 22.5 mg per vial every 3 months, Dr.
Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.
Administering goserelin acetate as an adjuvant treatment after radiotherapy increases long-term survival in patients with high-risk prostate cancer, according to results of a phase III trial of the Radiation Therapy Oncology Group led by Miljenko Pilepich, M.D., a radiation oncologist at the University of California, Los Angeles.
-- Pretreatment with goserelin acetate improves long-term outcomes in patients undergoing endometrial ablation for dysfunctional uterine bleeding, a recent study found.
Zeneca Pharmaceuticals has received FDA approval to marked ZOLADEX [R} (goserelin acetate implant) in combination with the anti-androgen flutamide prior to and during radiation therapy for managing early stages of prostate cancer (Stages 82-C -- disease locally confined to the prostate gland).
-- Zeneca Pharmaceuticals is promoting Zoladex (goserelin acetate) implants, which it has marketed for about four years for treating advanced prostate cancer, as a new therapy for endometriosis.
This suggested the goserelin acetate was stimulating FSH and LH secretion from his previously non-functioning pituitary macroadenoma.